Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0C3MW
|
|||
| Former ID |
DIB001027
|
|||
| Drug Name |
MBO7133
|
|||
| Indication | Liver cancer [ICD-11: 2C12; ICD-10: C22] | Phase 1/2 | [1] | |
| Company |
Metabasis Therapeutics Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human Deoxyribonucleic acid (hDNA) | Target Info | Binder | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Metabasis Therapeutics (2006). | |||
| REF 2 | Novel Cox-2 Inhibitor for Breast Cancer Therapy. Temple University School of Medicine Philadelphia, Pennsylvania 19140. July 2004. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.